Allarity Therapeutics (ALLR) Misses Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts ALLR Hot Sheet
Join SI Premium – FREE
Allarity Therapeutics (NASDAQ: ALLR) reported Q1 EPS of ($0.17).
For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yatsen Holding (YSG) Reports Q2 Loss of $0.16
- Kontoor Brands sets Helly Hansen revenue target above $1.1B by 2030
- Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
